Joel Greenblatt’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.9M | Buy |
37,598
+12,124
| +48% | +$5.6M | 0.05% | 569 |
|
|
2026
Q1 | $12.2M | Buy |
25,474
+8,232
| +48% | +$4.21M | 0.04% | 632 |
|
|
2025
Q4 | $9.68M | Buy |
17,242
+566
| +3% | +$321K | 0.04% | 644 |
|
|
2025
Q3 | $8.57M | Buy |
16,676
+2,300
| +16% | +$1M | 0.04% | 629 |
|
|
2025
Q2 | $4.51M | Buy |
14,376
+7,522
| +110% | +$2.26M | 0.03% | 696 |
|
|
2025
Q1 | $2.09M | Buy |
6,854
+1,101
| +19% | +$370K | 0.02% | 786 |
|
|
2024
Q4 | $1.91M | Sell |
5,753
-2,457
| -30% | -$833K | 0.02% | 734 |
|
|
2024
Q3 | $2.74M | Buy |
8,210
+2,327
| +40% | +$884K | 0.03% | 645 |
|
|
2024
Q2 | $2.42M | Sell |
5,883
-96
| -2% | -$38K | 0.03% | 625 |
|
|
2024
Q1 | $2.42M | Sell |
5,979
-1,008
| -14% | -$354K | 0.04% | 600 |
|
|
2023
Q4 | $2.14M | Sell |
6,987
-143
| -2% | -$38.6K | 0.04% | 579 |
|
|
2023
Q3 | $1.73M | Sell |
7,130
-1,000
| -12% | -$256K | 0.04% | 600 |
|
|
2023
Q2 | $1.95M | Sell |
8,130
-6,751
| -45% | -$1.4M | 0.04% | 552 |
|
|
2023
Q1 | $2.8M | Buy |
14,881
+6,764
| +83% | +$1.4M | 0.07% | 395 |
|
|
2022
Q4 | $1.72M | Sell |
8,117
-1,567
| -16% | -$313K | 0.05% | 477 |
|
|
2022
Q3 | $1.52M | Buy |
9,684
+371
| +4% | +$59.2K | 0.05% | 492 |
|
|
2022
Q2 | $1.39M | Buy |
9,313
+1,682
| +22% | +$243K | 0.04% | 468 |
|
|
2022
Q1 | $1.25M | Sell |
7,631
-262
| -3% | -$43.2K | 0.04% | 497 |
|
|
2021
Q4 | $1.72M | Sell |
7,893
-1
| -0% | -$209 | 0.06% | 394 |
|
|
2021
Q3 | $1.49M | Sell |
7,894
-186
| -2% | -$33.9K | 0.06% | 379 |
|
|
2021
Q2 | $1.43M | Sell |
8,080
-341
| -4% | -$58.9K | 0.06% | 399 |
|
|
2021
Q1 | $1.38M | Sell |
8,421
-526
| -6% | -$80.5K | 0.06% | 379 |
|
|
2020
Q4 | $1.25M | Sell |
8,947
-1,562
| -15% | -$197K | 0.04% | 485 |
|
|
2020
Q3 | $1.17M | Sell |
10,509
-9,093
| -46% | -$1.05M | 0.04% | 496 |
|
|
2020
Q2 | $1.82M | Sell |
19,602
-34,898
| -64% | -$2.97M | 0.05% | 415 |
|
|
2020
Q1 | $4M | Sell |
54,500
-31,435
| -37% | -$2.73M | 0.11% | 272 |
|
|
2019
Q4 | $7.22M | Sell |
85,935
-23,424
| -21% | -$1.81M | 0.13% | 219 |
|
|
2019
Q3 | $9.19M | Sell |
109,359
-21,533
| -16% | -$1.63M | 0.16% | 176 |
|
|
2019
Q2 | $8.56M | Sell |
130,892
-5,658
| -4% | -$326K | 0.14% | 200 |
|
|
2019
Q1 | $8.05M | Sell |
136,550
-14,978
| -10% | -$895K | 0.12% | 248 |
|
|
2018
Q4 | $8.02M | Buy |
+151,528
| New | +$8.32M | 0.12% | 240 |
|
|
2018
Q1 | – | Sell |
-9,789
| Closed | -$355K | – | 1022 |
|
|
2017
Q4 | $355K | Buy |
+9,789
| New | +$343K | 0.01% | 776 |
|
Other funds holding MEDP
WA
Joel Greenblatt's MEDP Position: Q2 2026 in Review
Joel Greenblatt increased its Medpace (MEDP) stake by 48% in Q2 2026, buying an estimated $5.6M and bringing the position to 37,598 shares worth $19.9M. The position accounts for 0.05% of the portfolio, ranked #569.
Joel Greenblatt first reported a position in MEDP in Q4 2017 and has held it in 32 quarters since. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Joel Greenblatt held 37,598 shares of Medpace worth $19.9M as of Q2 2026.
- Joel Greenblatt bought 12,124 Medpace shares in Q2 2026, an estimated $5.6M.
- Medpace made up 0.05% of Joel Greenblatt's portfolio in Q2 2026, its #569 holding.
- Joel Greenblatt first reported a position in Medpace in Q4 2017 and has held it in 32 quarters since.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.